Molecular diagnostics and serological methods for detecting COVID-19
Jude N Okoyeh, Teena Thomas
Coronavirus (COVID-19) is an ongoing pandemic disease that is caused by acute respiratory syndrome coronavirus2. WHO declared it has a public health emergency in early 2020 and since then many tests and methods have been developed to best prevent and possibly manage the spread of the virus. The disease has now been reported in over 223 countries globally. Detection of the virus in early stages will allow to stop the spread of the virus which would ultimately lower both the incident rates and the mortality rates. WHO have given Emergency Use Authorization (EUA) for various diagnostics methods and this review is mainly focused on the molecular diagnostics and serological methods of COVID-19 and to compare the advantages and disadvantages of these methods in clinical setting.